Cannabis tech company Akerna (NASDAQ:KERN) confirmed on Wednesday (December 18) it was buying fellow tech cannabis player Ample Organics for C$60 million.

The cash and stock transaction will bring on board a seed-to-sale platform company under the umbrella of Akerna. The public company highlighted Ample Organics’ capability to win a contract with St. Vincent and The Grenadines earlier this month to provide a national tracking platform through its AmpleCentral program.

Jessica Billingsley, CEO of Akerna, said integrating this purchase will give the company a stronger position in its pursuit to build a global technology platform.

In an email to the Investing News Network (INN) Billingsley said she’s confident the deal will close based on the synergy created between the two companies. The executive also praised its target acquisition for its partnership with the Caribbean nation.

“We anticipate the award will drive accelerated growth as international markets continue to pass legislation to legalize cannabis, and we look forward to working with Saint Vincent and the Grenadines,” Billingsley said.

“We believe this transaction will result in tremendous synergies and opportunities for both Ample Organics and Akerna,” John Prentice, founder and CEO of Ample Organics, said in a statement.

Akerna has committed to pay C$7.5 million in cash and C$42.5 million worth of Akerna stock. There will be an additional C$10 million of a stock-based consideration attached to targets the company must meet in 2020.

Shares of Akerna jumped during Wednesday’s trading session following the deal announcement. As of 1:30 p.m. EST, the company value was up 5.18 percent for a price per share of US$11.63.

The AmpleCentral program is designed to act as a “jurisdictional track-and-trace database” for governments in nascent cannabis markets to guarantee compliance and standards of its regulations.

“This technology connects data points across the national cannabis supply chain, providing regulators with the information necessary to assure public, product, and patient safety,” Ample Organics previously stated.

Following the confirmation of the partnership with St. Vincent and the Grenadines, Prentice said this would represent the first implementation of a national tracking system in the global cannabis industry.

According to Akerna, Ample Organics is projected to produce C$11.5 million in revenue for its 2020 operations. The company is expecting to close this transaction by Q1 2020.

Back in July, Ample Organics faced a significant round of layoffs, with approximately 20 employees losing their positions at the time, according to a report from BetaKit.

“It’s been an interesting time in the cannabis industry. There’s a lot … of turmoil happening. I think that capital is drying up in the space, and really Ample is a bellwether for everything else that’s going on in the industry,” Prentice said at the time of the cuts.

Previously, Billingsley told INN the firm’s NASDAQ listing provided it with significant opportunities for strategic mergers and acquisitions.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less

It’s been just over a year since recreational cannabis was legalised in the Australian Capital Territory (ACT), home to the nation’s capital city of Canberra.

Announced on September 25, 2019, and brought into effect on January 31, 2020, the rules make it legal to possess and personally use small amounts of cannabis.

Keep reading... Show less

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its fourth quarter 2020 financial results on Tuesday, March 23, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 7066881. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until March 30, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 7066881.

Keep reading... Show less